Skip to main content
. 2016 Jun 10;9:302. doi: 10.1186/s13104-016-2101-8

Fig. 1.

Fig. 1

Distribution of baseline antiretroviral drug class mutations among the 93 patients enrolled into the pre-treatment HIV Drug Resistance survey in Zimbabwe: 2008–2010